Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $120.42 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $46.54 | 3 | $0 (2021) |
| iRhythm Technologies, Inc. | $26.83 | 1 | $0 (2024) |
| Theravance Biopharma Inc. | $20.09 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $14.12 | 1 | $0 (2021) |
| Evofem Biosciences, Inc. | $12.84 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.83 | 1 | iRhythm Technologies, Inc. ($26.83) |
| 2021 | $60.21 | 4 | Novo Nordisk Inc ($33.25) |
| 2020 | $13.29 | 1 | Novo Nordisk Inc ($13.29) |
| 2017 | $20.09 | 1 | Theravance Biopharma Inc. ($20.09) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/02/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Obesity | ||||||
| 05/11/2021 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 03/08/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 11/20/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Diabetes | ||||||
| 12/05/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Infectious Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 164 | 214 | $73,693 | $21,607 |
| 2022 | 9 | 202 | 255 | $53,742 | $23,843 |
| 2021 | 7 | 129 | 155 | $34,480 | $16,015 |
| 2020 | 8 | 165 | 202 | $34,502 | $13,328 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 102 | $30,328 | $9,527 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $12,424 | $5,352 | 43.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $20,676 | $3,644 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 46 | $9,708 | $2,667 | 27.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $556.08 | $416.65 | 74.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 74 | $16,446 | $6,690 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $9,416 | $4,963 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 55 | $8,585 | $3,959 | 46.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $5,475 | $2,461 | 44.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $5,948 | $1,980 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,263 | $1,510 | 35.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 21 | $2,024 | $917.78 | 45.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $955.50 | $891.02 | 93.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $630.00 | $471.15 | 74.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 41 | $7,421 | $4,587 | 61.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 19 | $8,303 | $3,110 | 37.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $6,195 | $3,060 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 35 | $4,445 | $2,700 | 60.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $4,455 | $1,556 | 34.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 12 | 12 | $2,172 | $651.90 | 30.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 12 | 12 | $1,489 | $349.12 | 23.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 49 | 76 | $11,780 | $4,402 | 37.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $7,429 | $2,710 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 16 | 16 | $3,808 | $1,935 | 50.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 26 | 36 | $3,024 | $1,086 | 35.9% |
About Dr. Glea Mazzuca, D.O
Dr. Glea Mazzuca, D.O is a Internal Medicine healthcare provider based in Kennett Square, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2012. The National Provider Identifier (NPI) number assigned to this provider is 1376803502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glea Mazzuca, D.O has received a total of $120.42 in payments from pharmaceutical and medical device companies, with $26.83 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($120.42).
As a Medicare-enrolled provider, Mazzuca has provided services to 660 Medicare beneficiaries, totaling 826 services with total Medicare billing of $74,792. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Kennett Square, PA
- Active Since 05/22/2012
- Last Updated 10/20/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376803502
Products in Payments
- Ozempic (Drug) $33.13
- ZIO XT Patch (Device) $26.83
- VIBATIV (Drug) $20.09
- FARXIGA (Drug) $14.12
- Saxenda (Drug) $13.41
- Phexxi (Drug) $12.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kennett Square
Uzma Quraishi, Md, MD
Internal Medicine — Payments: $2,752
Karl Zimmerman, Md, MD
Internal Medicine — Payments: $962.82
Dr. Deepika Suri, M.d, M.D
Internal Medicine — Payments: $883.02
Dr. Paula Barry, Md, MD
Internal Medicine — Payments: $625.02
Ekinadose Oni
Internal Medicine — Payments: $25.20
Matthew Ochs, M.d, M.D
Internal Medicine